Neuro-Oncology Reviews

Volume 26 Number 2
31 January 2024

Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 2, 31 January

Caponnetto P, Schilirò G, Maglia M, Prezzavento GC, Baeken C, Quattropani MC.
Psychological and neuropsychological clinical impact in brain cancer patients and evidence-based psychological intervention: a systematic review of the literature.
Health Psychol Res. 2024 Jan 16;12:91408. doi: 10.52965/001c.91408. PMID: 38249780. Review. ˍ

Catalano M, Limatola C, Trettel F.
Non-neoplastic astrocytes: key players for brain tumor progression.
Front Cell Neurosci. 2024 Jan 16;17:1352130. doi: 10.3389/fncel.2023.1352130. PMID: 38293652. Review. ˍ

Shi W, Palmer JD, Alnahhas I.
Emerging insights on management of high-grade glioma.
Chin Clin Oncol. 2024 Jan 17:cco-23-109. doi: 10.21037/cco-23-109. PMID: 38247720. Editorial. ˍ

Alongi P, Arnone A, Vultaggio V, Fraternali A, Versari A, Casali C, Arnone G, DiMeco F, Vetrano IG.
Artificial Intelligence Analysis Using MRI and PET Imaging in Gliomas: A Narrative Review.
Cancers (Basel). 2024 Jan 18;16(2):407. doi: 10.3390/cancers16020407. PMID: 38254896. Review. ˍ

Ritchey AK et al., PDQ Pediatric Treatment Editorial Board.
Childhood Ependymoma Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Sum. 2024 Jan 18. NCBI-Bs ID: NBK65742. PMID 26389185. Review. ˍ

Shaw R, Basu M, Karmakar S, Ghosh MK.
MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives.
Biochim Biophys Acta Mol Cell Res. 2024 Jan 18;1871(3):119673. doi: 10.1016/j.bbamcr.2024.119673. PMID: 38242327. Review˰ ˍ


Yi L, Lin X, She X, Gao W, Wu M.
Chronic stress as an emerging risk factor for the development and progression of glioma.
Chin Med J (Engl). 2024 Jan 18. doi: 10.1097/CM9.0000000000002976. PMID: 38238191. Review. ˍ

Waldo-Benítez G, Padierna LC, Cerón P, Sosa MA.
Machine Learning in Magnetic Resonance Images of Glioblastoma: A Review.
Curr Med Imaging. 2024 Jan 19. doi: 10.2174/0115734056265212231122102029. PMID: 38258589. Review. ˍ

Jamshidi-Mouselou MS, Hashemi A, Jamshidi-Mouselou MS, Farkhondeh T, Pourhanifeh MH, Samarghandian S.
Application of Quercetin and its Novel Formulations in the Treatment of Malignancies of Central Nervous System: An Updated Review of Current Evidence Based on Molecular Mechanisms.
Curr Med Chem. 2024 Jan 23. doi: 10.2174/0109298673266672231121173432. PMID: 38265392. Review˰ ˍ

Zaresharifi N, Abbaspour E, Yousefzade-Chabok S, Reihanian Z, Karimian P, Karimzadhagh S.
Rare incidence of parietal lobe metastasis in an adult with desmoplastic/nodular medulloblastoma: A case report and review of the literature.
Int J Surg Case Rep. 2024 Jan 28;115:109322. doi: 10.1016/j.ijscr.2024.109322. PMID: 38281381. Case report, Review. ˍ

Liu D, Li Z.
Survival prediction using apparent diffusion coefficient values in recurrent glioblastoma under bevacizumab treatment: an updated systematic review and meta-analysis.
Diagn Interv Radiol. 2024 Jan 31. doi: 10.4274/dir.2024.232550. PMID: 38291976. Review, Meta-analysis. ˍ

Yaman I, Bouffet E.
How will tovorafenib change our treatment of pediatric low-grade glioma?
Expert Opin Emerg Drugs. 2024 Jan 31:1-3. doi: 10.1080/14728214.2024.2312817. PMID: 38293894. Editorial. ˍ

Ranjan S, Leung D, Ghiaseddin AP, Taylor JW, Lobbous M, Dhawan A, Budhu JA, Coffee E, Melnick K, Chowdhary SA, Lu-Emerson C, Kurz SC, Burke JE, Lam K, Patel MP, Dunbar EM, Mohile NA, Peters KB.
Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.
Cancer. 2024 Jan 30. doi: 10.1002/cncr.35220. PMID: 38288941. Guidelines˰ ˍ

Peters KB, Templer J, Gerstner ER, Wychowski T, Storstein AM, Dixit K, Walbert T, Melnick K, Hrachova M, Partap S, Ullrich NJ, Ghiaseddin AP, Mrgula M.
Discontinuation of Antiseizure Medications in Patients With Brain Tumors.
Neurology. 2024 Jan 31;102(4):e209163. doi: 10.1212/WNL.0000000000209163. PMID: 38290092. Review˰ ˍ

Singh E, Gurses ME, Costello MC, Lu VM, Daggubati L, Komotar RJ, Ivan ME, Shah AH.
Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
J Neurooncol. 2024 Jan 31. doi: 10.1007/s11060-024-04582-w. PMID: 38294637. Review˰ ˍ

Wilson JS, Main C, Thorp N, Taylor RE, Majothi S, Kearns PR, English M, Dandapani M, Phillips R, Wheatley K, Pizer B.
The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review.
J Neurooncol. 2024 Jan 31. doi: 10.1007/s11060-023-04510-4. PMID: 38294638. Review. ˍ